Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1β gene expression at steady-state and during the systemic stress induced by acute pancreatitis

Journal of Surgical Research

Volumn 63, Issue 1, 1996, Pages 231-236

  Norman, James G ^a   Fink, Gregory W ^a   Sexton, Cheryl ^a   Carter, Gay ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; ETHIONINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; MALE; MOUSE; MULTIPLE ORGAN FAILURE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR GENE; TRANSGENIC ANIMAL;

EID: 0029938312     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0253     Document Type: Conference Paper

References (36)

1. McKay, C., Gallagher, G., Baxter, J. N., and Imrie, C. W. Systemic complications in acute pancreatitis are associated with increased monocyte cytokine release. Gut 35: A575, 1994.
2. Gross, V., Leser, H. G., Heinisch, A., and Scholmerich, J. Inflammatory mediators and cytokines - new aspects of the pathophysiology and assessment of severity of acute pancreatitis. Hepatogastroenterology 40: 522-530, 1993.
3. Takeyama, Y., and Saitch, Y. Possible involvement of peritoneal macrophage activation in remote organ failure with acute pancreatitis. Proc. 55th Annu. Mtg. Soc. Univ. Surgeons, abstract number 136, 1994.
4. Heath, D. L., Cruickshank, D. H., Gudgeon, M., Jehanli, A., Shenkin, A., and Imrie, C. W. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Pancreas 66: 41-45, 1993.
5. Norman, J., Franz, M., Riker, A., Fabri, P. J., and Gower, W. R. Rapid elevation of pro-inflammatory cytokines during acute pancreatitis and their origination within the pancreas. Surg. Forum XLV: 148-160, 1994.
6. Norman, J., Fink, G., Franz, M., and Carter, G. Systemic cytokine gene expression induced by actue pancreatitis. Gastroenterology 108: A1236, 1995.
7. Norman, J., Messina, J., Franz, M., Fabri, P. J., Rosemurgy A. S., and Gower, W. R. Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117: 648-655, 1995.
8. Tanaka, N., Murata, A., Uda, K., Toda, H., Kato, T., Hayashida, H., Matsuura, N., and Mori, T. Interleukin-1 receptor antagonist modifies the changes in vital organs induced by acute necrotizing pancreatitis in a rat experimental model. Crit. Care Med. 23: 901-908, 1995.
9. Norman, J., Franz, M., Fink, G., Messina, J., Fabri, P. J., Gower, W. R., and Carey, L. C. Decreased mortality of severe acute pancreatitis following proximal cytokine blockade. Ann. Surg. 221: 456-463, 1995.
10. Norman, J., Fink, G., Carter, G., Davison, B., Glaccum, M., and Franz, M. Active interleukin-1 receptor required for maximal progression of acute pancreatitis. Ann. Surg. 223: 163-169, 1995.
11. Granowitz, E. V., Clark, B. D., Vannier, E., Callahan, M. V., and Dinarello, C. A. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood 79: 2356-2363, 1992.
12. Boermeester, M. A., vanLeeuwen, P. A., Coyle, S. M., Wolbrink, G. J., Hack, E., and Lowry, S. F. Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis. Arch. Surg. 130: 739-748, 1995.
13. Norman, J. G., Sutton, E. T., Franz, M., and Baker, C. H. Maintenance of dynamic microvascular function and structure in a rat model of endotoxic shock by blockade of the interleukin-1 receptor. Shock 3: 369-375, 1995.
14. Ohlsson, K., Bjork, P., Bergenfeldt, M., Hageman, R., and Thompson, R. C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 348: 550-552, 1990.
15. Dinarello, C. A. Interleukin-1 and interleukin-1 anagonism. Blood 77: 1627-1652, 1991.
16. Gersnwald, J. E., Fong, Y., and Fahey, T. J., III. Interleukin-1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 87: 4966-4970, 1990.
17. Vogels, M. T., Mensink, E. J., Ye, K., Boerman, O. C., Verschueren, C. M., Dinarello, C. A., and van der Meer, J. W. Diffenential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection. J. Immunol. 153: 5572-5780, 1994.
18. Evans, M. J., and Kaufmann, M. H. Establishment in culture of pluripotential cells from mouse embryo. Nature 292: 154-6, 1981.
19. Robertson, E. J. Embryo Derived Stem Cell Lines. Teratocarcinomas and Embryonic Stem Cells: Practical Approach, pp. 71-112. Oxford, UK: IRL, 1987.
20. Waldman, A. S. Targeted homologous recombination in mammalian cells. Crit. Rev. Oncol. Hematol. 12: 49-64, 1992.
21. Yeung, R. S., Penninger, J., and Mak, T. W. Genetically modified animals and immunodeficiency. Curr. Opin. Immunol. 5: 585-94, 1993.
22. Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S., and Flavell, R. A. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 265: 1-3, 1995.
23. Mansour, S. L., Thomas, K. R., and Capecci, M. R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general stratagy for targeting mutations to non-selectable genes. Nature 336: 348, 1988.
24. Tani, S., Otsuki, M., Itoh, H., Fujii, M., Nakamura, T., Oka, T., and Baba, S. Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulien stimulation. Int. J. Pancreatol. 2: 337-348, 1987.
25. Chomcyzynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
26. Dinarello, C. A. The interleukin-1 family: 10 years of discovery. FASEB J. 8: 1314-1325, 1994.
27. Bergers, G., Teikerstorfer, A., Braselmann, S., Graninger, P., and Busslinger, M. Alternative promoter usage of the Fos-responsive gene Tit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the Il-1 receptor. EMBO J. 13: 1176-1188, 1994.
28. Sims, J. E., Gayle, M. A., Slack, J. L., Alderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Mantovani, A., Shanebeck, K., Grabstein, K. H., and Dower, S. K. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. USA 90: 6155-6159, 1993.
29. Miyajaima, A., Kitamura, T., Harada, N., Yokata, T., and Kenichi, A. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10: 295-331, 1992.
30. Uhl, J., Newton, R. C., Giri, J. G., Sandlin, G., and Horuk, R. Identification of IL-1 receptors on human monocytes. J. Immunol. 142: 1576-1581, 1989.
31. Benjamin, D., Wormsly, S., and Dower, S. K. Heterogeneity on interleukin (IL)-1 receptors expressed on human B cell lines. Differences in the molecular properties of IL-1 binding sites. J. Biol. Chem. 265: 9943-9947, 1990.
32. Colotta, F., Re, F., Musio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J., Dower, S. K., Sims, J. E., and Mantovani, A. Interleukin-1 type II receptor: a decoy target for IL1 that is regulated by IL-4. Science 261: 472-475, 1993.
33. Oppenheim, J. J., Rossia, J. L., and Gearing, A. J. H. Clinical Applications of Cytokines; Role in Pathogenesis, Diagnosis and Therapy, pp. 1-42. New York: Oxford University Press, 1993.
34. DiGiovine, F. S., and Duff, G. W. Interleukin-1: the first interleukin. Immunol. Today 11: 13-20, 1990.
35. Lowry, S. F. Cytokine mediators of immunity and inflammation. Arch. Surg. 128: 1235-1, 1993.
36. Fink, G. W., and Norman, J. G. Intrapancreatic IL-1β gene expression by specific leukocyte populations during acute pancreatitis. J. Surg. Res. 63, 369-373.